Physician
Olitsa Roth, MD
Olitsa Roth, MD was paid $8.85M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoOLITSA ROTH, MD
BROOKLYN, NY 11219
BROOKLYN, NY 11219
33aNPI1407297245assigned 07/09/2013
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$8.85M
24GClaims271,620
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in New York
Rank by total paid#3 of 161
Median peer was paid$100K
This provider vs. median88×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,587 | $84K | |
| 2019 | 6,363 | $196K | |
| 2021 | 45,649 | $1.45M | |
| 2022 | 58,780 | $1.92M | |
| 2023 | 70,539 | $2.35M | |
| 2024incomplete | 87,702 | $2.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 41,971 | 34,359 | $4.05M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 8,209 | 7,839 | $1.12M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 5,865 | 5,860 | $656K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.5% | 5,088 | 5,085 | $571K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 3,528 | 3,515 | $367K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.1% | 6,405 | 5,931 | $365K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.8% | 2,749 | 2,749 | $338K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.4% | 13,087 | 12,980 | $213K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 10,693 | 5,769 | $146K |
| 87070 | 1.5% | 19,263 | 17,387 | $132K | |
| 87184 | 1.2% | 19,301 | 17,424 | $108K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 23,402 | 20,913 | $107K |
50 more codes
| 99050 | 1.0% | 12,263 | $93K | |
| 92551 | <1% | 9,768 | $83K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,712 | $80K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 427 | $53K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 5,097 | $51K |
| 69210 | <1% | 665 | $45K | |
| 96127 | <1% | 7,301 | $41K | |
| 99381 | <1% | 298 | $34K | |
| 99188 | <1% | 2,744 | $33K | |
| 85018 | <1% | 14,377 | $25K | |
| 83655 | <1% | 2,102 | $23K | |
| 90677 | <1% | 1,001 | $23K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,340 | $22K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,769 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,512 | $11K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 393 | $8K |
| 87807 | <1% | 611 | $7K | |
| 96160 | <1% | 2,445 | $7K | |
| 99173 | <1% | 7,558 | $5K | |
| 51701 | <1% | 81 | $4K | |
| 96161 | <1% | 987 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 33 | $3K |
| 99460 | <1% | 25 | $2K | |
| 81002 | <1% | 1,121 | $2K | |
| 17250 | <1% | 14 | $1K | |
| 94760 | <1% | 389 | $351.26 | |
| 90716 | <1% | 1,414 | $338.34 | |
| 97802 | <1% | 13 | $252.35 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $250.86 |
| 90715 | <1% | 411 | $216.14 | |
| 69209 | <1% | 12 | $148.52 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 48 | $59.30 |
| 90686 | <1% | 1,038 | $44.73 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 98 | $41.47 |
| 36415 | Collection of venous blood by venipuncture | <1% | 320 | $18.72 |
| 36416 | <1% | 16,345 | $4.48 | |
| 90744 | <1% | 2,106 | $0.01 | |
| 90619 | 0% | 597 | $0.00 | |
| 90698 | 0% | 2,341 | $0.00 | |
| 90647 | 0% | 246 | $0.00 | |
| 99000 | 0% | 393 | $0.00 | |
| 90656 | 0% | 97 | $0.00 | |
| 90707 | 0% | 1,457 | $0.00 | |
| 90734 | 0% | 358 | $0.00 | |
| 90670 | 0% | 1,706 | $0.00 | |
| 90713 | 0% | 808 | $0.00 | |
| 90700 | 0% | 1,520 | $0.00 | |
| 87400 | 0% | 410 | $0.00 | |
| 90710 | 0% | 54 | $0.00 | |
| 90633 | 0% | 222 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHNITZLER, ROSALYN (OFFICE MANAGER)